Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Latin America Sepsis Diagnostics Market: By Product, By Technology, By Pathogen Type, By Test Type and Country
Latin America Sepsis Diagnostics Market size was valued at US$ 180.9 million in 2023 and is expected to grow at a significant CAGR of 7.5% from 2024 to 2030. The market provides a detailed overview of the market that can be segmented By Product, Technology, Pathogen, and Testing Type. By Product, the market has been segmented into Microbiology, Molecular Diagnostics, Immunoassays, and Flow Cytometry. The Microbiology segment is likely to be the largest and fastest-growing segment in terms of Product. Based on pathogen type, the Latin America sepsis diagnostics market is segmented into Bacterial Sepsis, Fungal Sepsis, and Others. Â Among these, the bacterial sepsis segment is expected to have the fastest-growing market during the forecast period 2024-2030.
By Method, the market is segmented into Conventional Diagnostics and Automated Diagnostics. Conventional Diagnostics are expected to dominate the market in the future. Based on test type, the market has been segmented into Laboratory Tests and Point-Of-Care Tests. The laboratory tests segment is expected to grow at the highest CAGR over the forecast years. Based on the end-user, the market has been segregated into Hospitals, Pathology & Reference Laboratories. The Hospitals segment is to dominate other segments in the Latin America Sepsis Diagnostics market according to Precision Business Insights.
Key Development:
In January 2020, Roche and Inotrem SA, a France-based company, formed a strategic agreement for the commercialization of a companion diagnostics test intended for septic shock.
Study Period
2025-2031Base Year
2024CAGR
7.5%Largest Market
N/AFastest Growing Market
N/A
Factors such as the high prevalence of sepsis and the introduction of technologically advanced diagnostic solutions are expectesd to significantly fuel the market growth over the forecast period.
Report Benchmarks |
Details |
Report Study Period |
2025-2031 |
Market Size in 2023 |
US$ 180.9 million |
Market CAGR |
7.5% |
By Product Type |
|
By Technology |
|
By Pathogen Type |
|
Download Free Sample Report
The Latin America Sepsis Diagnostics Market size was valued at US$ 180.9 million in 2023
The Latin America Sepsis Diagnostics Market Report data: (Latin America Brazil Mexico Rest of LA)
The Latin America Sepsis Diagnostics Market key players are: Abbott Laboratories Inc. Beckman Coulter, Inc Becton, Dickinson, and Company BioMerieux SA Bruker Corporation Danaher Corporation Luminex Roche Diagnostics
1. Executive Summary |
2. Latin America Sepsis Diagnostics Market Introduction |
2.1. Latin America Sepsis Diagnostics Market Taxonomy |
2.2. Latin America Sepsis Diagnostics Market Definitions |
2.2.1. Product |
2.2.2. Technology |
2.2.3. Pathogen |
2.2.4. Testing Type |
3. Latin America Sepsis Diagnostics Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Latin America Sepsis Diagnostics Market Dynamic Factors - Impact Analysis |
3.6. Latin America Sepsis Diagnostics Market Competition Landscape |
4. Latin America Sepsis Diagnostics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Latin America Sepsis Diagnostics Market, By Product, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.1. Instruments |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Blood Culture Media |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Assay Kits and Reagents |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Software |
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
6. Latin America Sepsis Diagnostics Market Forecast, By Technology, 2019 - 2023 and Forecast, 2020 2026 (Revenue, USD Mn) |
6.1. Microbiology |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Molecular Diagnostics |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Immunoassays |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Flow Cytometry |
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
7. Latin America Sepsis Diagnostics Market Forecast, By Pathogen, 2019 - 2023 and Forecast, 2020 2026 (Revenue, USD Mn) |
7.1. Bacterial Sepsis |
7.1.1. Gram-positive Bacteria |
7.1.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.1.3. Market Opportunity Analysis |
7.1.2. Gram-negative Bacteria |
7.1.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.2.3. Market Opportunity Analysis |
7.2. Fungal Sepsis |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Others |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8. Latin America Sepsis Diagnostics Market Forecast, By Testing Type, 2019 - 2023 and Forecast, 2020 2026 (Revenue, USD Mn) |
8.1. Laboratory Testing |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. PoC Testing |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
9. Latin America Sepsis Diagnostics Market Forecast, By Region, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.1. Brazil |
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Mexico |
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Argentina |
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Rest of Latin America |
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Latin America Sepsis Diagnostics Market - Opportunity Analysis Index, By Product, Technology, Pathogen, Testing Type and Country, 2024 - 2030 |
10. Brazil Perfusion Systems Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
10.1. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Blood Culture Media |
10.1.2. Assay Kits and Reagents |
10.1.3. Software |
10.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.2.1. Microbiology |
10.2.2. Molecular Diagnostics |
10.2.3. Immunoassays |
10.2.4. Flow Cytometry |
10.3. Pathogen Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.3.1. Bacterial Sepsis |
10.3.1.1. Gram-positive Bacteria |
10.3.1.2. Gram-negative Bacteria |
10.3.2. Fungal Sepsis |
10.3.3. Others |
10.4. Testing Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.4.1. Laboratory Testing |
10.4.2. PoC Testing |
10.5. Brazil Perfusion Systems Market - Opportunity Analysis Index, By Product, Technology, Pathogen, Testing Type and Country, 2024 - 2030 |
10.6. Brazil Perfusion Systems Market Dynamics Trends |
11. Mexico Perfusion Systems Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
11.1. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Blood Culture Media |
11.1.2. Assay Kits and Reagents |
11.1.3. Software |
11.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.2.1. Microbiology |
11.2.2. Molecular Diagnostics |
11.2.3. Immunoassays |
11.2.4. Flow Cytometry |
11.3. Pathogen Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.3.1. Bacterial Sepsis |
11.3.1.1. Gram-positive Bacteria |
11.3.1.2. Gram-negative Bacteria |
11.3.2. Fungal Sepsis |
11.3.3. Others |
11.4. Testing Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.4.1. Laboratory Testing |
11.4.2. PoC Testing |
11.5. Mexico Perfusion Systems Market - Opportunity Analysis Index, By Product, Technology, Pathogen, Testing Type and Country, 2024 - 2030 |
11.6. Mexico Perfusion Systems Market Dynamics Trends |
12. Argentina Perfusion Systems Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
12.1. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Blood Culture Media |
12.1.2. Assay Kits and Reagents |
12.1.3. Software |
12.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.2.1. Microbiology |
12.2.2. Molecular Diagnostics |
12.2.3. Immunoassays |
12.2.4. Flow Cytometry |
12.3. Pathogen Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.3.1. Bacterial Sepsis |
12.3.1.1. Gram-positive Bacteria |
12.3.1.2. Gram-negative Bacteria |
12.3.2. Fungal Sepsis |
12.3.3. Others |
12.4. Testing Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.4.1. Laboratory Testing |
12.4.2. PoC Testing |
12.5. Argentina Perfusion Systems Market - Opportunity Analysis Index, By Product, Technology, Pathogen, Testing Type and Country, 2024 - 2030 |
12.6. Argentina Perfusion Systems Market Dynamics Trends |
13. Rest of Latin America Perfusion Systems Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
13.1. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.1.1. Blood Culture Media |
13.1.2. Assay Kits and Reagents |
13.1.3. Software |
13.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.2.1. Microbiology |
13.2.2. Molecular Diagnostics |
13.2.3. Immunoassays |
13.2.4. Flow Cytometry |
13.3. Pathogen Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.3.1. Bacterial Sepsis |
13.3.1.1. Gram-positive Bacteria |
13.3.1.2. Gram-negative Bacteria |
13.3.2. Fungal Sepsis |
13.3.3. Others |
13.4. Testing Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.4.1. Laboratory Testing |
13.4.2. PoC Testing |
13.5. Rest of Latin America Perfusion Systems Market - Opportunity Analysis Index, By Product, Technology, Pathogen, Testing Type and Country, 2024 - 2030 |
13.6. Rest of Latin America Perfusion Systems Market Dynamics Trends |
14. Competition Landscape |
14.1. Strategic Dashboard of Top Market Players |
14.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
14.2.1. Abbott Laboratories Inc. |
14.2.2. Beckman Coulter, Inc |
14.2.3. Becton, Dickinson, and Company |
14.2.4. BioMerieux SA |
14.2.5. Bruker Corporation |
14.2.6. Danaher Corporation |
14.2.7. Luminex |
14.2.8. Roche Diagnostics |
15. Research Methodology |
16. Key Assumptions and Acronyms |
Key Market Players